In Brief: Rhone-Poulenc Rorer/Applied Immune Sciences
Executive Summary
Rhone-Poulenc Rorer/Applied Immune Sciences: RPR and AIS sign definitive agreement whereby RPR will acquire the 54% of Santa Clara, Calif.-based AIS it does not already own for $11.75 per share, or approximately $84.4 mil. RPR expects the merger to close before year end...